Mechanism of resistance to the oncolytic C-nucleoside 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC-286193).

Authors :: Jayaram HN
Cooney DA
Glazer RI
Dion RL
Johns DG
Source :: Biochemical pharmacology [Biochem Pharmacol] 1982 Aug 01; Vol. 31 (15), pp. 2557-60.
Publication Year :: 1982

Subjects :: Animals
Antineoplastic Agents metabolism
Drug Resistance
Guanosine Triphosphate metabolism
Leukemia P388 metabolism
Mice
Neoplasm Transplantation
Ribavirin analogs & derivatives
Ribavirin metabolism
Time Factors
Antineoplastic Agents pharmacology
Leukemia P388 drug therapy
Leukemia, Experimental drug therapy
Ribavirin pharmacology
Ribonucleosides pharmacology

Full Text Access

Tools